SinglePass Kronos device shows promise for liver biopsy tract closure in small series
A retrospective, observational case report series evaluated the SinglePass Kronos electrocautery device for closing the biopsy tract after percutaneous liver mass biopsies in a small cohort of patients. The primary focus was on achieving hemostasis and tract closure, with secondary attention to bleeding complications and post-procedure imaging.
The authors reported that all biopsy procedures were technically successful. Over a 30-day follow-up period, they observed no complications, including an absence of bleeding. The series noted no serious adverse events or discontinuations related to the device.
Key limitations highlighted by the authors include the very small sample size and the non-comparative design, which preclude any conclusions about efficacy versus standard techniques. The findings are from a single-center experience without a control group.
Clinically, the authors suggest the device may be a valuable tool for minimizing bleeding in percutaneous solid organ biopsies, particularly in high-risk scenarios like liver masses. However, they caution that large-scale studies are warranted to confirm these preliminary observations and establish broader relevance.